Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06174285

Effect of Psychedelic VR-augmented Therapy on Patients With Clinical Depression

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
University of Tartu · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Research has demonstrated that psychedelic compounds possess significant therapeutic potential for a variety of disorders, including depression. Despite these findings, the underlying mechanisms driving the therapeutic efficacy of psychedelics remain elusive. Furthermore, there exists a debate over the contribution of the subjective psychedelic experience to their therapeutic benefits. In this study, virtual reality (VR) is utilized as a tool to replicate the subjective experiences induced by psychedelics, aiming to explore their impact on depressive symptoms within a clinical sample. The primary objective of this research is to examine the influence of psychedelic-like phenomenology, as simulated through VR, on depressive symptoms. The study is structured into two distinct arms: the experimental condition features 'Psyrreal,' a VR experience designed to emulate psychedelic effects and the control condition which includes 'Routine Realms,' an analogous VR experience devoid of psychedelic elements. A third waiting list condition may be included, dependent on the availability of sufficient participants and resources. Additionally, the study seeks to identify and analyze various potential mediators that might underpin the therapeutic outcomes observed.

Conditions

Interventions

TypeNameDescription
OTHERTherapeutic Intervention with Psychedelic Virtual RealityA 55-minute immersive psychedelic virtual reality experience is incorporated into a therapeutic intervention, comprising a preparatory phase and a subsequent integration session based on the individual's experience.
OTHERTherapeutic Intervention with Non-Psychedelic Virtual RealityA 55-minute immersive virtual reality experience is incorporated into a therapeutic intervention, comprising a preparatory phase and a subsequent integration session based on the individual's experience.

Timeline

Start date
2023-11-06
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2023-12-18
Last updated
2025-03-25

Locations

1 site across 1 country: Estonia

Source: ClinicalTrials.gov record NCT06174285. Inclusion in this directory is not an endorsement.